CRE, creatinine

Cre,肌酐
  • 文章类型: Journal Article
    根据ICHS3A问答,微量采样适用于药物和毒理学分析。很少有研究报道微量采样对免疫毒理学药物毒性的影响。这项多中心研究的目的是评估连续微量采样对硫唑嘌呤作为具有免疫毒性作用的模型药物治疗的大鼠的毒理学作用。在第1天至第2天的6个时间点和第27天至第28天的7个时间点从Sprague-Dawley大鼠的颈静脉收集50微升血液。该研究在三个组织中独立进行。微量采样对临床体征的影响,体重,食物消费,血液学参数,生化参数,尿参数,器官重量,并进行组织病理学评价。观察硫唑嘌呤引起的某些血液学和生化参数以及胸腺重量和病理的变化。微量采样对几乎所有参数产生的影响最小或没有影响;然而,在两个组织中,硫唑嘌呤诱导的变化显然掩盖了两个白细胞,一次凝结,和两个生化参数。总之,硫唑嘌呤毒性可以适当地评估为总体概况,即使使用血液微量采样。然而,微量采样可能会影响硫唑嘌呤引起的某些参数的变化,尤其是白细胞参数,它的用法应该仔细考虑。
    According to the ICH S3A Q&A, microsampling is applicable to pharmaceutical drugs and toxicological analysis. Few studies have reported the effect of microsampling on the toxicity of immunotoxicological drugs. The aim of this multicenter study was to evaluate the toxicological effects of serial microsampling on rats treated with azathioprine as a model drug with immunotoxic effects. Fifty microliters of blood were collected from the jugular vein of Sprague-Dawley rats at six time points from day 1 to 2 and 7 time points from day 27 to 28. The study was performed at three organizations independently. The microsampling effect on clinical signs, body weights, food consumption, hematological parameters, biochemical parameters, urinary parameters, organ weights, and tissue pathology was evaluated. Azathioprine-induced changes were observed in certain hematological and biochemical parameters and thymus weight and pathology. Microsampling produced minimal or no effects on almost all parameters; however, at 2 organizations, azathioprine-induced changes were apparently masked for two leukocytic, one coagulation, and two biochemical parameters. In conclusion, azathioprine toxicity could be assessed appropriately as overall profiles even with blood microsampling. However, microsampling may influence azathioprine-induced changes in certain parameters, especially leukocytic parameters, and its usage should be carefully considered.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这项研究旨在根据IFCC参考间隔和决策限制委员会(C-RIDL)的国际统一协议,为加纳成年人建立40种化学和免疫化学分析物的参考间隔(RI)。
    从加纳北部和南部地区招募了501名年龄≥18岁的健康志愿者。用Beckman-CoulterAU480和Centaur-XP/Siemen自动分析仪分析血液样品。通过多元回归分析(MRA)评估参考值(RV)的变化来源。按性别和年龄划分房车的需要由SD比率(SDR)指导。使用参数方法并应用潜在异常值排除(LAVE)方法得出每种分析物的RI。
    使用SDR≥0.4作为阈值,房车按性别划分大多数酶,肌酐,尿酸(UA),胆红素,免疫球蛋白M.MRA显示年龄和体重指数(BMI)是许多分析物变化的主要来源。LAVE降低了丙氨酸/天冬氨酸转氨酶RI的上限,γ-谷氨酰转氨酶和脂质。排除BMI≥30的个体进一步降低了血脂和CRP的RI。在基于C-RIDL提供的价值分配血清面板进行标准化后,加纳发现肌酸激酶RI较高,淀粉酶,与其他合作国家相比,白蛋白和尿素含量较低。
    对许多临床化学RI的LAVE效应支持对可靠衍生RI的次级排除的需要。加纳RI与其他国家相比的差异强调了特定国家RI对改善临床决策的重要性。
    This study is aimed at establishing reference intervals (RIs) of 40 chemistry and immunochemistry analytes for Ghanaian adults based on internationally harmonized protocol by IFCC Committee on Reference Intervals and Decision Limits (C-RIDL).
    A total of 501 healthy volunteers aged ≥18 years were recruited from the northern and southern regions of Ghana. Blood samples were analyzed with Beckman-Coulter AU480 and Centaur-XP/Siemen auto-analyzers. Sources of variations of reference values (RVs) were evaluated by multiple regression analysis (MRA). The need for partitioning RVs by sex and age was guided by the SD ratio (SDR). The RI for each analyte was derived using parametric method with application of the latent abnormal values exclusion (LAVE) method.
    Using SDR≥0.4 as threshold, RVs were partitioned by sex for most enzymes, creatinine, uric acid (UA), bilirubin, immunoglobulin-M. MRA revealed age and body mass index (BMI) as major source of variations of many analytes. LAVE lowered the upper limits of RIs for alanine/aspartate aminotransferase, γ-glutamyl transaminase and lipids. Exclusion of individuals with BMI≥30 further lowered the RIs for lipids and CRP. After standardization based on value-assigned serum panel provided by C-RIDL, Ghanaian RIs were found higher for creatine kinase, amylase, and lower for albumin and urea compared to other collaborating countries.
    The LAVE effect on many clinical chemistry RIs supports the need for the secondary exclusion for reliable derivation of RIs. The differences in Ghanaian RIs compared to other countries underscore the importance of country specific-RIs for improved clinical decision making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    长期以来,马兜铃酸(AAs)由于其肾毒性而被认为是有效的致癌物。马兜铃酸I(AAI)与DNA反应形成共价的马兜铃内酰胺(AL)-DNA加合物,导致随后的A到T变性突变,通常称为AA突变签名。先前的研究推断,AA广泛涉及整个亚洲的肝癌。在这项研究中,我们探讨了AAs暴露是否是中国大陆HBV感染背景下肝癌的主要原因。从3个医学中心随机检索到1256份肝癌样本,并使用精细的生物分析方法检测AAI-DNA加合物。这些样品中的5.10%可被鉴定为AAI阳性暴露。全基因组测序显示,107例肝癌患者中有8.41%表现出显性AA突变特征,表明AAI总体暴露率相对较低。在动物模型中,长期服用AAI几乎不会增加成年小鼠的肝脏肿瘤发生,与其在婴儿小鼠体内的诱导肿瘤作用相反。此外,AAI诱导成年小鼠靶器官中AA-DNA加合物的剂量依赖性积累,检测最多的是肾脏而不是肝脏。一起来看,我们的数据表明,AA暴露不是成年期肝癌的主要威胁.
    Aristolochic acids (AAs) have long been considered as a potent carcinogen due to its nephrotoxicity. Aristolochic acid I (AAI) reacts with DNA to form covalent aristolactam (AL)-DNA adducts, leading to subsequent A to T transversion mutation, commonly referred as AA mutational signature. Previous research inferred that AAs were widely implicated in liver cancer throughout Asia. In this study, we explored whether AAs exposure was the main cause of liver cancer in the context of HBV infection in mainland China. Totally 1256 liver cancer samples were randomly retrieved from 3 medical centers and a refined bioanalytical method was used to detect AAI-DNA adducts. 5.10% of these samples could be identified as AAI positive exposure. Whole genome sequencing suggested 8.41% of 107 liver cancer patients exhibited the dominant AA mutational signature, indicating a relatively low overall AAI exposure rate. In animal models, long-term administration of AAI barely increased liver tumorigenesis in adult mice, opposite from its tumor-inducing role when subjected to infant mice. Furthermore, AAI induced dose-dependent accumulation of AA-DNA adduct in target organs in adult mice, with the most detected in kidney instead of liver. Taken together, our data indicate that AA exposure was not the major threat of liver cancer in adulthood.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    癌症仍然是全球死亡的主要原因之一,转移总是导致治疗失败。这里,我们开发了一种多功能的水凝胶加载光热剂,化疗药物,和免疫佐剂通过联合治疗根除原位肿瘤并抑制转移。通过聚多巴胺(PDA)与硫醇化透明质酸的硫醇-迈克尔加成合成了水凝胶网络。PDA作为交联剂,赋予水凝胶优异的光热性能。同时,化疗药物,多柔比星(DOX),通过PDA和免疫佐剂的π-π堆叠加载到水凝胶中,CpG-ODN,是通过静电相互作用加载的。DOX从水凝胶中的释放最初是缓慢的,但由于近红外光照射而加速。水凝胶对4T1癌细胞表现出明显的协同作用,并刺激RAW264.7细胞分泌大量细胞因子。此外,在瘤内注射和光照射后,水凝胶根除了原位鼠乳腺癌异种移植物,并强烈抑制了转移。这种化学-光热免疫疗法的高抗癌效率是由多功能水凝胶的强协同作用引起的。包括诱发的宿主免疫反应。化学-光热免疫疗法的组合策略有望用于乳腺癌的高效治疗。
    Cancer remains one of the leading causes of death globally and metastasis always leads to treatment failure. Here, we develop a versatile hydrogel loading photothermal agents, chemotherapeutics, and immune-adjuvants to eradicate orthotopic tumors and inhibit metastasis by combinational therapy. Hydrogel networks were synthesized via the thiol-Michael addition of polydopamine (PDA) with thiolated hyaluronic acid. PDA acted as a cross-linking agent and endowed the hydrogel with excellent photothermal property. Meanwhile, a chemotherapeutic agent, doxorubicin (DOX), was loaded in the hydrogel via π‒π stacking with PDA and an immune-adjuvant, CpG-ODN, was loaded via electrostatic interaction. The release of DOX from the hydrogel was initially slow but accelerated due to near infrared light irradiation. The hydrogels showed remarkably synergistic effect against 4T1 cancer cells and stimulated plenty of cytokines secreting from RAW264.7 cells. Moreover, the hydrogels eradicated orthotopic murine breast cancer xenografts and strongly inhibited metastasis after intratumoral injection and light irradiation. The high anticancer efficiency of this chemo-photothermal immunotherapy resulted from the strong synergistic effect of the versatile hydrogels, including the evoked host immune response. The combinational strategy of chemo-photothermal immunotherapy is promising for highly effective treatment of breast cancer.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    尽管几种人工纳米疗法已被批准用于转移性乳腺癌的实际治疗,他们低效的治疗结果,严重的不良影响,大规模生产的高成本仍然是关键的挑战。在这里,我们开发了一种替代策略,通过使用来自茶花的天然纳米载体(TFEN)特异性触发乳腺肿瘤细胞凋亡并抑制其肺转移.这些纳米载体具有理想的粒径(131nm),外泌体样形态,和负zeta电位。此外,TFEN被发现含有大量的多酚,黄酮类化合物,功能蛋白,和脂质。细胞实验表明,由于刺激活性氧(ROS)扩增,TFEN对癌细胞显示出强细胞毒性。细胞内ROS数量的增加不仅可以触发线粒体损伤,但也阻止细胞周期,导致体外抗增殖,反移民,和抗乳腺癌细胞侵袭活性。进一步的小鼠研究表明,静脉内(i.v.)注射或口服给药后的TFEN可以在乳腺肿瘤和肺转移部位积聚,抑制乳腺癌的生长和转移,并调节肠道微生物群。这项研究为通过静脉内和口服途径抑制乳腺癌及其肺转移的天然外泌体样纳米平台的绿色生产带来了新的见解。
    Although several artificial nanotherapeutics have been approved for practical treatment of metastatic breast cancer, their inefficient therapeutic outcomes, serious adverse effects, and high cost of mass production remain crucial challenges. Herein, we developed an alternative strategy to specifically trigger apoptosis of breast tumors and inhibit their lung metastasis by using natural nanovehicles from tea flowers (TFENs). These nanovehicles had desirable particle sizes (131 nm), exosome-like morphology, and negative zeta potentials. Furthermore, TFENs were found to contain large amounts of polyphenols, flavonoids, functional proteins, and lipids. Cell experiments revealed that TFENs showed strong cytotoxicities against cancer cells due to the stimulation of reactive oxygen species (ROS) amplification. The increased intracellular ROS amounts could not only trigger mitochondrial damage, but also arrest cell cycle, resulting in the in vitro anti-proliferation, anti-migration, and anti-invasion activities against breast cancer cells. Further mice investigations demonstrated that TFENs after intravenous (i.v.) injection or oral administration could accumulate in breast tumors and lung metastatic sites, inhibit the growth and metastasis of breast cancer, and modulate gut microbiota. This study brings new insights to the green production of natural exosome-like nanoplatform for the inhibition of breast cancer and its lung metastasis via i.v. and oral routes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    化疗和免疫疗法的结合通过引发免疫原性细胞死亡(ICD)来激发强大的免疫系统,在抑制肿瘤生长和改善免疫抑制肿瘤微环境(ITM)方面显示出巨大的潜力。然而,低劣的药物生物利用度限制了治疗效果。在这里,我们报道了一种通用的生物响应性阿霉素(DOX)基纳米凝胶,可实现肿瘤特异性药物共递送。设计并选择基于DOX的甘露糖纳米凝胶(DMNG)作为示例,以阐明联合化学免疫疗法的机制。不出所料,DMNG表现出显著的胶束稳定性,选择性药物释放和延长生存时间,受益于增强肿瘤通透性和延长血液循环。我们发现由DMNG递送的DOX可以通过促进ICD来诱导强大的抗肿瘤免疫应答。同时,从DMNGs释放的甘露糖被证明在体外和体内对乳腺癌具有强大的协同治疗作用,通过破坏糖酵解和三羧酸循环中的葡萄糖代谢。总的来说,基于DOX的纳米凝胶对肿瘤微环境的调节有望成为一种有效的候选策略,以克服基于ICD的免疫治疗的当前局限性。为免疫调节纳米药物的开发提供了范例。
    The combination of chemotherapy and immunotherapy motivates a potent immune system by triggering immunogenic cell death (ICD), showing great potential in inhibiting tumor growth and improving the immunosuppressive tumor microenvironment (ITM). However, the therapeutic effectiveness has been restricted by inferior drug bioavailability. Herein, we reported a universal bioresponsive doxorubicin (DOX)-based nanogel to achieve tumor-specific co-delivery of drugs. DOX-based mannose nanogels (DM NGs) was designed and choosed as an example to elucidate the mechanism of combined chemo-immunotherapy. As expected, the DM NGs exhibited prominent micellar stability, selective drug release and prolonged survival time, benefited from the enhanced tumor permeability and prolonged blood circulation. We discovered that the DOX delivered by DM NGs could induce powerful anti-tumor immune response facilitated by promoting ICD. Meanwhile, the released mannose from DM NGs was proved as a powerful and synergetic treatment for breast cancer in vitro and in vivo, via damaging the glucose metabolism in glycolysis and the tricarboxylic acid cycle. Overall, the regulation of tumor microenvironment with DOX-based nanogel is expected to be an effectual candidate strategy to overcome the current limitations of ICD-based immunotherapy, offering a paradigm for the exploitation of immunomodulatory nanomedicines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    关于糖尿病肾病(DN)中组织特异性代谢重编程的详细知识对于更准确地理解分子病理学特征和开发新的治疗策略至关重要。在本研究中,提出了一种基于空气流动辅助解吸电喷雾电离(AFADESI)和基质辅助激光解吸电离(MALDI)整合质谱成像(MSI)的空间分辨代谢组学方法,以研究高脂饮食喂养和链脲佐菌素(STZ)治疗的DN大鼠肾脏的组织特异性代谢变化以及黄芪甲苷的治疗作用,一种潜在的抗糖尿病药物,对DN。因此,广泛的功能性代谢物,包括糖,氨基酸,核苷酸及其衍生物,脂肪酸,磷脂,鞘脂,甘油酯,肉碱及其衍生物,维生素,肽,并鉴定了与DN相关的金属离子,并以高化学特异性和高空间分辨率显示了它们在大鼠肾脏中的独特分布模式。通过反复口服黄芪甲苷(100mg/kg)12周可改善这些特定区域的代谢紊乱。这项研究提供了有关糖尿病大鼠肾脏组织特异性代谢重编程和分子病理学特征的更全面和详细信息。这些发现强调了AFADESI和MALDI整合的基于MSI的代谢组学方法在代谢性肾脏疾病中的应用潜力。
    Detailed knowledge on tissue-specific metabolic reprogramming in diabetic nephropathy (DN) is vital for more accurate understanding the molecular pathological signature and developing novel therapeutic strategies. In the present study, a spatial-resolved metabolomics approach based on air flow-assisted desorption electrospray ionization (AFADESI) and matrix-assisted laser desorption ionization (MALDI) integrated mass spectrometry imaging (MSI) was proposed to investigate tissue-specific metabolic alterations in the kidneys of high-fat diet-fed and streptozotocin (STZ)-treated DN rats and the therapeutic effect of astragaloside IV, a potential anti-diabetic drug, against DN. As a result, a wide range of functional metabolites including sugars, amino acids, nucleotides and their derivatives, fatty acids, phospholipids, sphingolipids, glycerides, carnitine and its derivatives, vitamins, peptides, and metal ions associated with DN were identified and their unique distribution patterns in the rat kidney were visualized with high chemical specificity and high spatial resolution. These region-specific metabolic disturbances were ameliorated by repeated oral administration of astragaloside IV (100 mg/kg) for 12 weeks. This study provided more comprehensive and detailed information about the tissue-specific metabolic reprogramming and molecular pathological signature in the kidney of diabetic rats. These findings highlighted the promising potential of AFADESI and MALDI integrated MSI based metabolomics approach for application in metabolic kidney diseases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    纯药物组装纳米药物(PDAN)目前正在深入研究,作为有前途的癌症治疗纳米平台。然而,较差的胶体稳定性和较少的肿瘤归巢能力仍然是阻碍其临床转化的关键问题。在这里,我们报道了一种用于光动力治疗(PDT)的纤芯匹配纳米组装体(PPa).发现纯PPa分子自组装成纳米颗粒(NP),和两亲性PEG聚合物(PPa-PEG2K)用于通过π-π堆积效应和PPa核与PPa-PEG2K壳之间的疏水相互作用实现核匹配的聚乙二醇化修饰。与具有相似分子量的PCL-PEG2K相比,PPa-PEG2K显著增加稳定性,延长体循环,提高PPa纳米组装的肿瘤归巢能力和ROS生成效率。因此,PPa/PPa-PEG2KNP在带有4T1乳腺肿瘤的BALB/c小鼠异种移植模型中发挥有效的抗肿瘤活性。一起,这种核匹配的纯光敏剂纳米组装体为开发成像引导的热不可知纳米药物提供了新的策略.
    Pure drug-assembled nanomedicines (PDANs) are currently under intensive investigation as promising nanoplatforms for cancer therapy. However, poor colloidal stability and less tumor-homing ability remain critical unresolved problems that impede their clinical translation. Herein, we report a core-matched nanoassembly of pyropheophorbide a (PPa) for photodynamic therapy (PDT). Pure PPa molecules are found to self-assemble into nanoparticles (NPs), and an amphiphilic PEG polymer (PPa-PEG2K) is utilized to achieve core-matched PEGylating modification via the π‒π stacking effect and hydrophobic interaction between the PPa core and the PPa-PEG2K shell. Compared to PCL-PEG2K with similar molecular weight, PPa-PEG2K significantly increases the stability, prolongs the systemic circulation and improves the tumor-homing ability and ROS generation efficiency of PPa-nanoassembly. As a result, PPa/PPa-PEG2K NPs exert potent antitumor activity in a 4T1 breast tumor-bearing BALB/c mouse xenograft model. Together, such a core-matched nanoassembly of pure photosensitizer provides a new strategy for the development of imaging-guided theragnostic nanomedicines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Journal Article
    鱼酱产品,鱼丸\'tsumire\',是一种传统的日本食物,由碎鱼和仿蟹制成,kamaboko和hanpen.尽管tsumire被称为高蛋白和低脂肪的食物,缺乏有关其健康益处的科学证据。因此,作为一项初步研究,我们旨在研究摄入tsumire对Sprague-Dawley大鼠84d器官重量和生物标志物水平的影响。将6周龄雄性Sprague-Dawley大鼠分为两组:I组,喂正常饮食,和第二组,用5%干tsumire喂养正常饮食。在整个管理期间,我们监测了他们的体重和食物摄入量;在这段时间结束时,我们测量了他们的器官重量并分析了他们的血液生化。在体重方面没有观察到显著差异,食物摄入量,两组之间的器官重量和许多生化指标。发现II组大鼠的无机磷和葡萄糖水平高于I组大鼠。另一方面,钠,钙,淀粉酶和胆碱酯酶水平在II组显著低于I组。我们发现天冬氨酸氨基转移酶的水平,丙氨酸转氨酶,II组的乳酸脱氢酶和亮氨酸氨基肽酶明显低于I组,并且II组的其他肝功能参数倾向于低于I组。我们认为日本的传统食物,\'tsumire,\'可以作为全球人类健康管理的功能食品有效。
    The fish paste product, fish balls \'tsumire\', is a traditional type of Japanese food made from minced fish as well as imitation crab, kamaboko and hanpen. Although tsumire is known as a high-protein and low-fat food, there is a lack of scientific evidence on its health benefits. Hence, we aimed to investigate the effects of tsumire intake on organ weight and biomarker levels in Sprague-Dawley rats for 84 d as a preliminary study. Six-week-old male Sprague-Dawley rats were divided into two groups: group I, fed normal diets, and group II, fed normal diets with 5 % dried tsumire. Throughout the administration period, we monitored their body weight and food intake; at the end of this period, we measured their organ weight and analysed their blood biochemistry. No significant differences were observed with respect to body weight, food intake, organ weight and many biochemical parameters between the two groups. It was found that inorganic phosphorus and glucose levels were higher in group II rats than in group I rats. On the other hand, sodium, calcium, amylase and cholinesterase levels were significantly lower in group II than in group I. Interestingly, we found that the levels of aspartate aminotransferase, alanine transaminase, lactate dehydrogenase and leucine aminopeptidase in group II were significantly lower than in group I, and that other liver function parameters of group II tended to be lower than in group I. In conclusion, we consider that the Japanese traditional food, \'tsumire,\' may be effective as a functional food for human health management worldwide.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    化疗是批准用于治疗中晚期肝细胞癌(HCC)的有限选择之一。为了使药物的治疗指数最大化,需要在患病部位优先和长时间的药物暴露。这里,我们报道了一种可注射的超分子肽水凝胶作为腹腔内储库,用于局部和持续释放雷公藤甲素治疗原位HCC。我们选择了肽两亲物C16-GNNQQNYKD-OH基纳米纤维作为雷公藤甲素的胶凝剂和载体。在体外14天内实现了水凝胶中雷公藤甲素的持续释放。与L-02胎儿肝细胞相比,人HCCBel-7402的积累和细胞毒性更高。腹膜内注射后,水凝胶显示出13天的长期保留和在肝脏中的优先积累,实现肝癌生长抑制99.7±0.1%,动物中位生存期从19天延长到43天,不会在主要器官中引起明显的病理变化。这些结果表明,可注射肽水凝胶可以成为肝癌局部化疗的潜在载体。
    Chemotherapy is among the limited choices approved for the treatment of hepatocellular carcinoma (HCC) at intermediate and advanced stages. Preferential and prolonged drug exposure in diseased sites is required to maximize the therapeutic index of the drug. Here, we report an injectable supramolecular peptide hydrogel as an intraperitoneal depot for localized and sustained release of triptolide for the treatment of orthotopic HCC. We chose peptide amphiphile C16-GNNQQNYKD-OH-based nanofibers as gelators and carriers for triptolide. Sustained triptolide release from the hydrogel was achieved over 14 days in vitro, with higher accumulation in and cytotoxicity against human HCC Bel-7402 in comparison with L-02 fetal hepatocytes. After intraperitoneal injection, the hydrogel showed prolonged retention over 13 days and preferential accumulation in the liver, realizing HCC growth inhibition by 99.7 ± 0.1% and animal median survival extension from 19 to 43 days, without causing noticeable pathological changes in the major organs. These results demonstrate that injectable peptide hydrogel can be a potential carrier for localized chemotherapy of HCC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号